<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02207296</url>
  </required_header>
  <id_info>
    <org_study_id>2014-A00330-47</org_study_id>
    <nct_id>NCT02207296</nct_id>
  </id_info>
  <brief_title>Operative Hemodynamic Optimization Using the Plethysmographic Variability Index During Orthopedic Surgery</brief_title>
  <acronym>OPVI</acronym>
  <official_title>Operative Hemodynamic Optimization Using the Plethysmographic Variability Index During Orthopedic Surgery : a Multicentric Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether an operative hemodynamic optimization using
      the plethysmographic variability index during orthopedic surgery could decrease the length of
      hospital stay and the postoperative morbidity.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of hospital stay after knee or hip arthroplasty</measure>
    <time_frame>Real length of hospital stay expressed as number of day (maximum 60 days)</time_frame>
    <description>Surgeons, blinded to the group allocation, are the postoperative care providers who decide the length of hospital stay.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Troponin value</measure>
    <time_frame>Postoperative Day 1 and Day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine value</measure>
    <time_frame>Postoperative Day 1 and Day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial Lactate</measure>
    <time_frame>1 hour after end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative cardiac complications</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 1 week, until postoperative day 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Theorical length of hospital stay after knee or hip arthroplasty</measure>
    <time_frame>Theorical length of hospital stay expressed as number of day (maximum 60 days)</time_frame>
    <description>Evaluation twice per day starting day 3 until up day 60. A check list was used by an independant investigator to define the theorical date of end hospitalisation, from day 3 until day 60</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Medico economic evaluation</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 1 week, until postoperative day 60</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Hip Arthroplasty</condition>
  <condition>Knee Arthroplasty</condition>
  <condition>General Anesthesia</condition>
  <arm_group>
    <arm_group_label>PVI group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Fluid optimisation using PVI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard care using a hemodynamic protocol during general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Plethysmographic variability index</intervention_name>
    <arm_group_label>PVI group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Indication to a knee or hip arthroplasty under general anesthesia

          -  Sinusal rhythm

        Non Inclusion Criteria:

          -  Pregnant women

          -  Black skin

          -  Dialysis

          -  Cardiac arrythmia

          -  Sepsis

          -  Use of another hemodynamic monitoring during surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marc-Olivier Fischer, MD</last_name>
    <phone>+33 231 064 736</phone>
    <email>fischer-mo@chu-caen.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <zip>14 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Olivier Fisher</last_name>
      <phone>+33 231 06 3303</phone>
      <email>fischer-mo@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Marc Olivier Fischer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2014</study_first_submitted>
  <study_first_submitted_qc>July 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2014</study_first_posted>
  <last_update_submitted>September 10, 2015</last_update_submitted>
  <last_update_submitted_qc>September 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

